Phase II clinical trial of multimodal analgesia for postoperative pain management in patients undergoing laparoscopic colorectal resection for cancer

Phase II clinical trial of multimodal analgesia for postoperative pain management in patients undergoing laparoscopic colorectal resection for cancer - Phase II clinical trial of multimodal analgesia in patients undergoing laparoscopic colorectal resection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028240

Enrollment

Registered

2017-07-14

Start date

2017-07-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Multimodal analgesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: # Pathologically proven carcinoma. # Primary tumor located at colon or upper rectum # Rectal cancers of which the lower border is located below the peritoneal reflection are excluded. # Aged 20 to 85 years old # Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 # Written informed consent

Exclusion criteria

Exclusion criteria: # Allergy to any drugs used in this trial Distant metastases # Interstitial pneumonia or fibroid lung. # Uncontrolled diabetes mellitus. # Uncontrolled hypertension # Uncontrolled urinary disorder # Unable to provide informed consent # Those considered inappropriate for participation in this trial.

Design outcomes

Primary

Measure	Time frame
Postoperative stay	—

Secondary

Measure	Time frame
Pain score (NRS,PRS), postoperative complications, frequency of PCA, time to walk, time to food intake	—

Countries

Japan

Contacts

Public ContactShohko Matsukawa

Kindai University Surgery

profsec-matsukawa@surg.med.kindai.ac.jp072-366-0221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026